Natco Pharma About us
Since its establishment in 1981, NATCO Pharma has been involved in the research, development, manufacturing, and marketing of pharmaceutical products. NATCO operates its business in 2 segments: pharmaceutical and crop health sciences. The firm makes both FDFs (Finished Dosage Forms) and APIs (Active Pharmaceutical Ingredients) across therapeutic areas such as oncology, gastroenterology and hepatology, neurology, infectious diseases, cardiology, and diabetology.
Moreover, NATCO has developed over 75 APIs and has over 30 years of experience in API development. Under its crop health segment, the firm offers agrochemical products including insecticides, fungicides, herbicides, and plant growth promoters. Furthermore, its manufacturing facilities are situated across Telangana, Andhra Pradesh, Uttarakhand, Assam, and Tamil Nadu.
Natco Pharma Rights Issue Review
- N/A
Natco Pharma Rights Issue 2026 Dates & Time Table
| Rights Issue Open: | October 12, 2026 |
| Rights Issue Close: | October 22, 2026 |
| Rights Record Date: | October 1, 2026 |
| Last Date to Buy Shares: | September 30, 2026 |
| Deemed Date of Allotment | October 23, 2026 |
| Renunciation of Rights Entitlements | October 16, 2026 |
Natco Pharma Rights Issue 2026 Offer Details
| Rights Issue Size: | Approx ₹1,279.36 Crores |
| Price Band: | ₹750 Per Equity Share |
| Face Value: | ₹2 Per Equity Share |
| Listing on: | BSE, NSE |
| Entitlement Ratio: | 2:21 (2 rights share for every 21 shares) |
| Equity: | 1,70,58,082 Equity Share |
| Letter of Offer: | Click Here |
| Application Form: | Click Here |
| Live Share Price: | Click Here |
Natco Pharma Rights Issue 2026 Form & How to Apply
You can apply for Natco Pharma Rights Issue 2026 in two ways:
- Net Banking (ASBA)
- Registrar’s Website (R-WAP Facility)
Natco Pharma Financial Report
| ₹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2024 | ₹4,126.90 | ₹2,453.40 | ₹1,388.30 |
| 2025 | ₹4,784.00 | ₹2,492.60 | ₹1,883.40 |
| 2026 | ₹4,375.90 | ₹2,885.10 | ₹1,371.90 |
Natco Pharma Rights Issue 2026 Allotment Status
Kfin Technologies Ltd.
Phone: 040-79615565
Email: natcopharma.rights@kfintech.com
Website: https://ipostatus.kfintech.com/
Natco Pharma Rights Issue 2026 Lead Managers
- To Be Updated Soon
Company Address:
Natco Pharma Ltd.
‘NATCO House”
Road No. 2
Banjara Hills
Hyderabad, 500034
Phone: 914023547532
Email: investors@natcopharma.co.in
Website: https://www.natcopharma.co.in/
Natco Pharma Rights Issue 2026 FAQs:
When is Natco Pharma Rights Issue 2026 Record Date?
What is Natco Pharma Rights Issue 2026 Price?
What is the Natco Pharma Rights Issue 2026 Ratio?
How to apply for Natco Pharma Rights Issue 2026?
Follow IPO Watch for the Upcoming IPO News and their reviews, also keep following us on Twitter, Facebook, and Instagram. For our latest videos, subscribe to our YouTube channel.
